MBI for Psychological Distress, SI and NSSI Among Young Adults

February 9, 2024 updated by: Sadia Sohail, Fatima Jinnah Women University

Impact of Mindfulness Based Therapeutic Intervention on Psychological Distress, Suicidal Ideation and Non-Suicidal Self Injury Among Young Adults: A Randomized Controlled Trial

Designed to measure the impact of Mindfulness Based Intervention on depression, anxiety, stress, psychological distress, Suicidal Ideation, Non-Suicidal Self Injury urge and Mindfulness in young adults. Those individuals who agree to participate in the trial and identified with high levels of psychological distress and Suicidal Ideation, randomly divided into interventional (n=30) and control (n=30) groups. The Mindfulness Based Stress Reduction intervention then administered to the interventional group for eight weeks and pre and post intervention assessment done for both the groups.

Study Overview

Detailed Description

Study assessment measures:

  • Informed consent form
  • Demographic questionnaire
  • Screener questions form
  • Assessment instruments:
  • Depression Anxiety and Stress Scale (DASS-21)
  • Suicide Ideation Scale (SIS)
  • Alexian Brothers Urge to Self Injure Scale (ABUSI)
  • Mindfulness Attention Awareness Scale

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Rawalpindi, Punjab, Pakistan, 46000
        • Fatima Jinnah Women University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants aged 18-24, of any gender, who consented to participate and could comprehend English (the language of the questionnaires).
  • Selected respondents from the initial survey were included based on specific criteria:
  • Willingness to continue participation.
  • Unmarried status.
  • Pursuing education (Bachelors, Masters, or Ph.D.) , Pakistan.
  • Non-hosteller and unemployed.
  • Residing with both parents.
  • Affirmative response to screener questions about suicidal ideation (SI) and non-suicidal self-injury (NSSI).
  • High scores on psychological distress and SI scales.

Exclusion Criteria:

  • Participants failing to meet inclusion criteria or falling under the following categories were excluded:
  • Non-students.
  • History of present or past psychiatric illness, with recent medication or treatment within the past year.
  • Presence of debilitating physical diseases or disabilities. Involvement in or history of substance use.
  • Long-term medication for any condition, as these factors could impact study results.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional Group (Receiving Mindfulness Based Intervention)
after the young adults have been randomized into interventional and control groups based on high levels of psychological distress, SI and NSSI, n=30 participants from this group would receive the mindfulness based intervention.
During an eight-week intervention period, clients were to engage in mindfulness practices lasting between 45 minutes to an hour each session. The intervention would incorporate various components of the Mindfulness-Based Stress Reduction (MBSR) program, including mindfulness of the present moment, body scans, mindful eating, walking meditation, yoga exercises, and discussions on applying mindfulness to everyday experiences and stress management. Sessions would typically range from 30 to 90 minutes per week, with an additional full-day retreat session towards the end of the program. In addition to mindfulness practice, participants were to receive teachings on stress management and its application to interpersonal and daily life situations.
No Intervention: Control Group (No Intervention)
A wait list control group of n=30 randomized participants from the initial cohort would be in this group and receive no intervention, until the trial is completed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological Distress
Time Frame: 8-12 weeks
This refers to the overall level of emotional suffering or discomfort experienced by individuals, often encompassing symptoms of depression, anxiety, and stress. In this study, psychological distress serves as a primary outcome measure because it is a key variable being assessed in relation to the intervention's efficacy.
8-12 weeks
Suicidal Ideation
Time Frame: 8-12 weeks
Suicidal ideation involves thoughts or ideas about engaging in behaviors intended to end one's life. As a primary outcome measure, assessing suicidal ideation is crucial in understanding the impact of the intervention on the participants' mental health and risk of self-harm.
8-12 weeks
Non-Suicidal Self-Injury (NSSI)
Time Frame: 8-12 weeks
NSSI refers to deliberate, self-inflicted harm to one's body without suicidal intent, such as cutting or burning oneself. It is an essential primary outcome measure in this study because it directly relates to the intervention's effectiveness in reducing self-harming behaviors among participants.
8-12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2022

Primary Completion (Actual)

May 28, 2022

Study Completion (Actual)

May 28, 2022

Study Registration Dates

First Submitted

February 9, 2024

First Submitted That Met QC Criteria

February 9, 2024

First Posted (Actual)

February 16, 2024

Study Record Updates

Last Update Posted (Actual)

February 16, 2024

Last Update Submitted That Met QC Criteria

February 9, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Within the ethical considerations, results of research would be shared via research publications.

IPD Sharing Time Frame

When research is published.

IPD Sharing Access Criteria

Through open access journal publications.

IPD Sharing Supporting Information Type

  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidal Ideation

Clinical Trials on Mindfulness Based Stress Reduction Intervention

3
Subscribe